Closing Bell: Hls Therapeutics Inc down on Tuesday (HLS)
Hls Therapeutics Inc opened trading today at $3.06 and closed at $3.01. It traded at a low of $3.01 to a high of $3.09.
The price shrank -4.44 percent from the previous day's close of $3.15.
During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.
Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.
A total of 1,900 shares was traded during the last trading day, with total trades of 7, while having an average volume of 1,049 over the last 5-days.
The TSX market on the whole today saw 3,772 price advancers against 1,443 declines and 86 unchanged.
During the prior 52 weeks, HLS.TO has traded as high as $5.95 (August 09,2023) and low as $3.01 (August 06,2024). Moreover, in the last 12 months, Hls Therapeutics Inc's shares have shrunken -49.16%, while they have decreased -23.80% since the start of 2024.
It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.
Following today's trading, Hls Therapeutics Inc has a market capitalization of $100.22 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.
Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.
Hls Therapeutics Inc is holding an average recommendation of "Moderate Buy" from 5.00 analysts according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
